SCHEMBL3852265

SCHEMBL3852265

N#Cc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2I)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.37
MAPK13 O15264 1/20 0.37
RAF1 P04049 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
ALDH1A3 P47895 1/20 0.36
TSHR P16473 2/20 0.35
CXCR2 P25025 1/20 0.34
PRKDC P78527 1/20 0.34
CYP19A1 P11511 2/20 0.33
BAZ2B Q9UIF8 1/20 0.33
BAZ2A Q9UIF9 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
ADORA2A P29274 1/20 0.33
MERTK Q12866 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847981 0.86 ADORA2A (0.43) ALDH1A3GABRA1GABRG2GABRB3GABRA5
SCHEMBL3845762 0.81 PRKDC (0.36) KIF11MAPK13RAF1MAPK12MAPK11
SCHEMBL3847403 0.69 ALDH1A1 (0.36) TSHRADORA2AMEN1KMT2A
SCHEMBL28916303 0.68 AURKA (0.39) TSHRCYP19A1ADORA2AMEN1KMT2A
SCHEMBL3848166 0.68 ADORA2A (0.41) ALDH1A3TSHRPRKDCGABRA1GABRG2
SCHEMBL519563 0.67 KDM4E (0.36) TSHRMEN1KMT2AATM
SCHEMBL23607308 0.67 ALDH1A3 (0.57) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL23234347 0.67 ALDH1A3 (0.57) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL23234338 0.67 ALDH1A3 (0.57) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL22405796 0.66 ALDH1A1 (0.38) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed